| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3c2e77f8dfda692ca527454d23ecc03 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46 |
| filingDate |
1990-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1991-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15259e488bed0353d3a25cf2b5f6cb4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99a73f7cacf011ebf33cfa91777c66e0 |
| publicationDate |
1991-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5030637-A |
| titleOfInvention |
Anisodamine to prevent and treat eye disease |
| abstract |
A method is disclosed for the prevention and alleviation of pathologic changes in the eye such as diabetic retinopathy or senile macular degeneration. The claimed method involves the parenteral administration of anisodamine in an amount effective for preventing or alleviating these pathogenic changes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6599928-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6491938-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8158670-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6515009-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8067022-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8097642-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010113260-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6569441-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6720350-B2 |
| priorityDate |
1988-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |